Genomics for the Average Joe

Nathaniel Harooni
Genomics investing doesn't have to be complicated. Let's dive in, together.
Created 06 Jun 2021
17
Posts
79
Likes
11
Comments
2
Mentions
  • Biotech2K1 Master Threads:
    17 Sep 2021 • 9 min read
    PAMPS (Pathogen Associated Molecular Patterns) We hear about the receptors of immune cells every day in biotech like T cell receptors or B cell receptors, but we never hear about the many receptors of...
  • @Biotech2K1 Master Threads:
    17 Sep 2021 • 10 min read
    INNATE UMMUNITY The Immune System is actually a very complex network of tissues and cells all working together to protect us from pathogens and kill mutated cells. The Immune system falls into two arm...
  • @Biotech2K1 Master Threads:
    17 Sep 2021 • 5 min read
    TOLL LIKE RECEPTOR PATHWAY To know what a Toll Like Receptor is, first you need to know what a little about immunology. I will back track a bit and give you a bit of background. Sentry immune cells li...
  • @Biotech2K1 Master Threads:
    17 Sep 2021 • 4 min read
    IP3/DAG Pathway This pathway starts with the activation of a GPCR with an alpha q subunit. The alpha q subunit will displace its GDP and replace it with a GTP. This will allow it to disassociate form ...
  • @Biotech2K1 Master Threads:
    17 Sep 2021 • 3 min read
    SECONDARY MESSENGERS These pathways are typically called the second messengers as they are the other things cells must do when they are responding to the growth pathways like MAPK and mTOR. These are ...
  • @Biotech2K1 Master Threads:
    17 Sep 2021 • 4 min read
    mTOR pathway Pt 1: This is a very complex pathway, and I will most likely have to break it down over a few threads. The mammalian Target of Rapamycin (mTOR) pathway monitors all the nutrients coming i...
  • @Biotech2K1 Master Threads:
    16 Sep 2021 • 18 min read
    CELL TO CELL COMMUNICATION Cells communicate for many reasons. They will communicate to take in nutrients, to grow, or even respond to stimulus. One great example is our immune system cells. The sentr...
  • @Biotech2K1 Master Threads:
    16 Sep 2021 • 3 min read • 2 1
    Disclaimer: All of @Biotech2K1’s Master Threads posts are sourced directly and unadulterated from Twitter. @Biotech2K1 has given me consent to repost his threads to my readers contingent that they are...
  • @Biotech2K1 Master Threads:
    16 Sep 2021 • 6 min read • 4 0
    Disclaimer: All of @Biotech2K1’s Master Threads posts are sourced directly and unadulterated from Twitter. @Biotech2K1 has given me consent to repost his threads to my readers contingent that they are...
  • Kymera Therapeutics (NASDAQ: KYMR)
    06 Aug 2021 5 0
    Read more
  • View More on Substack »